SEC Info - Biolase, Inc - ‘10-K’ for 12/31/13

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.28M 
 2: EX-4        Ex-4.4                                              HTML     29K 
 3: EX-10       Ex-10.42                                            HTML     61K 
 4: EX-21       Ex-21.1                                             HTML     21K 
 5: EX-23       Ex-23.1                                             HTML     23K 
 6: EX-31       Ex-31.1                                             HTML     29K 
 7: EX-31       Ex-31.2                                             HTML     29K 
 8: EX-32       Ex-32.1                                             HTML     25K 
 9: EX-32       Ex-32.2                                             HTML     25K 
53: R1          Document and Entity Information                     HTML     53K 
43: R2          Consolidated Balance Sheets                         HTML    144K 
51: R3          Consolidated Balance Sheets (Parenthetical)         HTML     51K 
55: R4          Consolidated Statements Of Operations And           HTML    107K 
                Comprehensive Loss                                               
71: R5          Consolidated Statements Of Shareholders' Equity     HTML    101K 
                (Deficit)                                                        
45: R6          Consolidated Statements Of Cash Flows               HTML    176K 
50: R7          Basis of Presentation                               HTML     55K 
39: R8          Summary of Significant Accounting Policies          HTML    152K 
30: R9          Supplementary Balance Sheet Information             HTML    122K 
72: R10         Intangible Assets and Goodwill                      HTML     92K 
57: R11         Lines of Credit and Other Borrowings                HTML     44K 
56: R12         Income Taxes                                        HTML    190K 
62: R13         Commitments and Contingencies                       HTML     56K 
63: R14         Stockholders' Equity                                HTML    274K 
61: R15         Segment Information                                 HTML     49K 
64: R16         Concentrations                                      HTML     26K 
52: R17         Subsequent Events                                   HTML     38K 
54: R18         Schedule II-Consolidated Valuation and Qualifying   HTML     88K 
                Accounts and Reserves                                            
60: R19         Accounting Policies (Policies)                      HTML    306K 
76: R20         Summary of Significant Accounting Policies          HTML    109K 
                (Tables)                                                         
67: R21         Supplementary Balance Sheet Information (Tables)    HTML    129K 
47: R22         Intangible Assets and Goodwill (Tables)             HTML     83K 
58: R23         Income Taxes (Tables)                               HTML    183K 
49: R24         Commitments and Contingencies (Tables)              HTML     31K 
24: R25         Stockholders' Equity (Tables)                       HTML    229K 
68: R26         Segment Information (Tables)                        HTML     41K 
73: R27         Basis of Presentation - Additional Information      HTML     52K 
                (Detail)                                                         
34: R28         Estimated Useful Lives of Property, Plant and       HTML     28K 
                Equipment (Detail)                                               
33: R29         Changes in Initial Product Warranty Accrual and     HTML     41K 
                Expenses Under Initial and Extended Warranties                   
                (Detail)                                                         
37: R30         Classification of Compensation Expense Associated   HTML     32K 
                with Share-Based Payments (Detail)                               
38: R31         Assumptions Used in Estimating Fair Value of Stock  HTML     35K 
                Options Granted (Detail)                                         
40: R32         Summary of Significant Accounting Policies -        HTML     57K 
                Additional Information (Detail)                                  
22: R33         Components of Accounts Receivable, Net of           HTML     31K 
                Allowance (Detail)                                               
65: R34         Components of Inventory (Detail)                    HTML     34K 
46: R35         Summary of Property, Plant, and Equipment (Detail)  HTML     45K 
48: R36         Components of Accrued Liabilities (Detail)          HTML     51K 
27: R37         Summary of Deferred Revenue (Detail)                HTML     40K 
75: R38         Supplementary Balance Sheet Information -           HTML     48K 
                Additional Information (Detail)                                  
16: R39         Intangible Assets and Related Accumulated           HTML     56K 
                Amortization (Detail)                                            
41: R40         Intangible Assets and Goodwill - Additional         HTML     44K 
                Information (Detail)                                             
70: R41         Lines of Credit and Other Borrowings - Additional   HTML    137K 
                Information (Detail)                                             
26: R42         Summary of Income Tax Current and Deferred          HTML     69K 
                Provision (Benefit) (Detail)                                     
32: R43         Federal Income Tax Provision Compared With          HTML     63K 
                Statutory Rates (Detail)                                         
36: R44         Summary of Net Deferred Tax Assets and Net          HTML     87K 
                Deferred Tax Liabilities (Detail)                                
44: R45         Summary of Unrecognized Tax Benefits (Detail)       HTML     31K 
21: R46         Income Taxes - Additional Information (Detail)      HTML     58K 
29: R47         Commitments and Contingencies - Additional          HTML     41K 
                Information (Detail)                                             
18: R48         Future Minimum Rental Commitments Under Operating   HTML     45K 
                Lease Agreements (Detail)                                        
69: R49         Summary of Option Activity (Detail)                 HTML     81K 
25: R50         Options Outstanding and Exercisable (Detail)        HTML     70K 
66: R51         Cash Proceeds Along with Fair Value Disclosures     HTML     41K 
                Related to Grants Exercises and Vesting Options                  
                (Detail)                                                         
28: R52         Stockholders' Equity - Additional Information       HTML    251K 
                (Detail)                                                         
42: R53         Summary of Net Revenue by Geographic Location       HTML     27K 
                (Detail)                                                         
17: R54         Segment Information - Additional Information        HTML     32K 
                (Detail)                                                         
20: R55         Concentrations - Additional Information (Detail)    HTML     36K 
35: R56         Subsequent Events - Additional Information          HTML     67K 
                (Detail)                                                         
23: R57         Consolidated Valuation and Qualifying Accounts and  HTML     36K 
                Reserves (Detail)                                                
74: XML         IDEA XML File -- Filing Summary                      XML    111K 
19: EXCEL       IDEA Workbook of Financial Reports                  XLSX    190K 
31: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   2.05M 
10: EX-101.INS  XBRL Instance -- biol-20131231                       XML   2.69M 
12: EX-101.CAL  XBRL Calculations -- biol-20131231_cal               XML    200K 
13: EX-101.DEF  XBRL Definitions -- biol-20131231_def                XML   1.08M 
14: EX-101.LAB  XBRL Labels -- biol-20131231_lab                     XML   1.53M 
15: EX-101.PRE  XBRL Presentations -- biol-20131231_pre              XML   1.21M 
11: EX-101.SCH  XBRL Schema -- biol-20131231                         XSD    220K 
59: ZIP         XBRL Zipped Folder -- 0001564590-14-000856-xbrl      Zip    215K

‘R10’ — Intangible Assets and Goodwill

This is an IDEA Financial Report. [ Alternative Formats ]

Intangible Assets and Goodwill

12 Months Ended

Dec. 31, 2013

Intangible Assets and Goodwill

NOTE 4 — INTANGIBLE ASSETS AND GOODWILL

The Company conducted its annual two-step impairment test of intangible assets and goodwill as of June 30, 2013 and determined that there was no impairment. The Company also tests its intangible assets and goodwill between the annual impairment test if events occur or circumstances change that would more likely than not reduce the fair value of the Company or its assets below their carrying amounts. No events have occurred that triggered further impairment testing of the Company’s intangible assets and goodwill during the years ended December 31, 2013 and 2012.

Amortization expense for the years ended December 31, 2013, 2012, and 2011, totaled $117,000, $136,000, and $130,000, respectively. Estimated intangible asset amortization expense, based on existing intangible assets, for the years ending December 31, 2014, 2015, and 2016, is $69,000, $62,000, and $52,000, respectively.

The following table presents the details of the Company’s intangible assets, related accumulated amortization and goodwill (in thousands):

	As of December 31, 2013									As of December 31, 2012
	Gross		Accumulated Amortization			Impairment		Net		Gross		Accumulated Amortization			Impairment		Net
Patents (4-10 years)	$	1,914	$	(1,895	)	$	—	$	19	$	1,914	$	(1,833	)	$	—	$	81
Trademarks (6 years)		69		(69	)		—		—		69		(69	)		—		—
Other (4 to 6 years)		817		(653	)		—		164		817		(598	)		—		219
Total	$	2,800	$	(2,617	)	$	—	$	183	$	2,800	$	(2,500	)	$	—	$	300
Goodwill (Indefinite life)	$	2,926						$	2,926	$	2,926						$	2,926

In December 2012, the Company capitalized approximately $224,000 related to intangible assets acquired from its former distributor in India. These assets primarily include a non-compete agreement and customer and luminary lists. Of the total capitalized balance, $200,000 was a noncash investment whereby the Company reduced the accounts receivable from its former distributor in exchange for these assets. The Company is amortizing these assets on a straight-line basis over the expected useful life of four years and has recognized amortization expense of approximately $55,000 and $5,000 related to these intangible assets during the years ended December 31, 2013 and 2012, respectively.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details

Dates Referenced Herein and Documents Incorporated by Reference

This ‘10-K’ Filing	Date	Other Filings

	12/31/16	10-K, SD
	12/31/15	10-K, SD
	12/31/14	10-K, 10-K/A, SD
Filed on:	3/17/14	8-K/A, DEFA14A
For Period end:	12/31/13	10-K/A, SD
	6/30/13	10-Q
	12/31/12	10-K
	12/31/11	10-K, 10-K/A
	9/15/09
		List all Filings

↑Top

Filing Submission 0001564590-14-000856 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Biolase, Inc – ‘10-K’ for 12/31/13 – ‘R10’

On: Monday, 3/17/14, at 4:22pm ET · For: 12/31/13 · Accession #: 1564590-14-856 · File #: 0-19627

Previous ‘10-K’: ‘10-K’ on 3/15/13 for 12/31/12 · Next: ‘10-K/A’ on 4/30/14 for 12/31/13 · Latest: ‘10-K’ on 3/21/24 for 12/31/23

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

‘R10’ — Intangible Assets and Goodwill

This is an IDEA Financial Report. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

Biolase, Inc – ‘10-K’ for 12/31/13 – ‘R10’

On: Monday, 3/17/14, at 4:22pm ET · For: 12/31/13 · Accession #: 1564590-14-856 · File #: 0-19627

Previous ‘10-K’: ‘10-K’ on 3/15/13 for 12/31/12 · Next: ‘10-K/A’ on 4/30/14 for 12/31/13 · Latest: ‘10-K’ on 3/21/24 for 12/31/23

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34Filing Table of Contents

‘R10’ — Intangible Assets and Goodwill

This is an IDEA Financial Report. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents